GlassScriptPhysician profile
Dennis Cortes
NPI 1013198118
$12,197.64
in general payments reported to CMS, 2019-2025
58 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,814 · 2020: $1,979 · 2021: $1,827 · 2022: $1,468 · 2023: $1,517 · 2024: $1,386 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,110.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,859.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,136.95 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,053.69 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $843.37 | 2019-2025 | Qulipta, Ubrelvy, Linzess |
| Lilly USA, LLC | $612.26 | 2019-2025 | Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $610.72 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $566.20 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $465.64 | 2019-2023 | |
| Allergan, INC. | $394.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.33 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $262.20 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Glaxosmithkline, LLC. | $255.78 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Kvk-Tech, INC. | $223.64 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $191.55 | 2022 | |
| Insulet Corporation | $185.72 | 2021-2024 | Omnipod |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Cortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.